RBNE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RBNE is not a good buy right now. With no proprietary buy signals, weak near-term pattern-based downside odds, and deteriorating profitability metrics (EPS and gross margin down sharply YoY), the current setup favors staying on the sidelines rather than buying at 4.40—especially for an impatient buyer looking for immediate follow-through.
Price/Trend: RBNE is down -9.43% in the regular session (pre-market +0.82%), signaling strong near-term selling pressure. Momentum: MACD histogram is positive (0.181) but positively contracting, which often points to weakening bullish momentum rather than a fresh up-leg. RSI: RSI(6) at 67.783 is near the upper-neutral area (close to overbought), which reduces the attractiveness of chasing a bounce after volatility. Moving averages: Converging MAs suggest consolidation/indecision rather than a clean trend. Key levels: Pivot 4.069 is the near support; price 4.40 is above pivot but still below resistance R1 4.776. A break below 4.069 increases risk of a move toward S1 3.363. Pattern-based outlook: Similar candlestick-pattern analysis implies a drift lower (-0.13% next day, -1.39% next week, -6.85% next month), which does not support an “enter now” decision.
Intellectia Proprietary Trading Signals
Pre-market is slightly positive (+0.82%), suggesting some dip-buying interest after the sharp selloff. Price is still above the pivot support (4.069), so a technical bounce is possible if support holds.
Sharp intraday drop (-9.43%) indicates active selling and weak near-term sentiment. MACD momentum is weakening (positive but contracting). Pattern-based projections skew negative over the next week/month. No recent news flow to act as an upside catalyst. No hedge fund/insider accumulation trend reported.
Latest quarter: 2025/Q3. Revenue rose to 1,962,635 (0.00% YoY) and net income increased to 98,337 (0.00% YoY), indicating essentially flat growth. However, EPS fell to 0.01 (-98.08% YoY) and gross margin dropped to 36.11 (-32.81% YoY), showing meaningful profitability deterioration despite stable top-line/net income figures—overall a negative quality signal for near-term bullish positioning.
No analyst rating or price-target change data was provided, so a Wall Street pros/cons view cannot be confirmed from the dataset. Based on available fundamentals/technicals alone: pros are potential support-based bounce and positive (but fading) MACD; cons are weak profitability trend (EPS/margins), lack of catalysts, and bearish near-term pattern probabilities.
Influential/congress trading: No recent congress trading data available; hedge funds and insiders are reported as neutral with no significant recent trends.
